Overview
Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors. Vilazodone may also be associated with less sexual dysfunction and weight gain. Vilazodone was given FDA approval on January 21, 2011.
Indication
用于治疗成人重度抑郁症（MDD）。
Associated Conditions
- Major Depressive Disorder (MDD)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/10/16 | Phase 4 | Not yet recruiting | |||
2023/07/19 | N/A | Completed | Mental Health Services in the Capital Region, Denmark | ||
2023/07/17 | Phase 2 | Not yet recruiting | Global Coalition for Adaptive Research | ||
2023/07/03 | Not Applicable | Recruiting | First Affiliated Hospital of Zhejiang University | ||
2022/09/13 | N/A | Recruiting | University Hospital Muenster | ||
2022/06/16 | Phase 2 | Recruiting | Global Coalition for Adaptive Research | ||
2022/05/02 | N/A | UNKNOWN | |||
2022/03/07 | Phase 1 | Withdrawn | |||
2021/04/05 | N/A | UNKNOWN | |||
2021/02/10 | Phase 2 | Active, not recruiting | Ajay Wasan, MD, Msc |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Allergan, Inc. | 0456-1110 | ORAL | 10 mg in 1 1 | 4/1/2024 | |
| Apotex Corp | 60505-4774 | ORAL | 40 mg in 1 1 | 7/28/2023 | |
| NorthStar RxLLC | 72603-127 | ORAL | 40 mg in 1 1 | 12/2/2022 | |
| Accord Healthcare Inc. | 16729-352 | ORAL | 10 mg in 1 1 | 12/13/2023 | |
| NorthStar RxLLC | 72603-126 | ORAL | 20 mg in 1 1 | 12/2/2022 | |
| Exelan Pharmaceuticals Inc. | 76282-546 | ORAL | 40 mg in 1 1 | 3/27/2023 | |
| Novadoz Pharmaceuticals LLC | 72205-261 | ORAL | 20 mg in 1 1 | 6/30/2023 | |
| Cipla USA Inc. | 69097-981 | ORAL | 20 mg in 1 1 | 1/9/2023 | |
| Teva Pharmaceuticals, Inc. | 0480-2043 | ORAL | 40 mg in 1 1 | 1/31/2022 | |
| NorthStar RxLLC | 72603-125 | ORAL | 10 mg in 1 1 | 12/2/2022 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.